Impact of nicotine concentration, form, and stereoisomer ratio on oral nicotine pouch pharmacokinetics and abuse liability: Protocol for a randomized crossover study in adults who use tobacco

OBJECTIVES: Oral nicotine pouches (ONPs) are tobacco-free products placed between the lip and gum to deliver nicotine. Sales have grown rapidly in the United States (U.S.), yet independent data on how nicotine characteristics shape ONP appeal and addiction potential are lacking. Three nicotine characteristics vary across ONPs: concentration (mass of nicotine per pouch), form (the fraction of freebase, or unprotonated, nicotine), and stereoisomer (the proportion of S- to R-nicotine). This study will determine how these characteristics independently and jointly affect ONP nicotine pharmacokinetics and user experience among adults who smoke cigarettes or use moist snuff. DESIGN AND PARTICIPANTS: This randomized, double-blind, crossover trial will enroll 160 adults who smoke cigarettes or use moist snuff at a single U.S. site. INTERVENTIONS AND OUTCOMES: Participants will be randomized 1:1 to a lower (3 mg) or higher (6 mg) nicotine concentration arm. Within each arm, participants will complete five laboratory sessions in balanced, randomized order: four standardized ONP sessions (30 minutes, with the pouch placed between lip and gum) varying by nicotine form (30% vs. 70% freebase) and stereoisomer ratio (racemic [50% R- and 50% S-nicotine] vs. > 99% S-nicotine), plus one session using their usual tobacco product. Sessions will be separated by at least 48 hours. The primary outcome is maximum plasma nicotine concentration (Cmax). Secondary outcomes include time to maximum concentration (Tmax), total nicotine absorbed over 90 minutes (AUC), subjective effects, and behavioral economic demand indices. CONCLUSIONS: This will be the first study to systematically examine how nicotine concentration, form, and stereoisomer ratio interact to influence ONP abuse liability. Findings will identify which product characteristics drive ONP addiction potential and will inform FDA regulation aimed at maximizing the potential for ONPs to serve as a harm reduction alternative to cigarettes and moist snuff. TRIAL REGISTRATION: ClinicalTrials.gov NCT06315881; registered February 14, 2024.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-11-16
DOI
https://doi.org/10.1371/journal.pone.0362198
Primary Topic
Smoking Behavior and Cessation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Impact of nicotine concentration, form, and stereoisomer ratio on oral nicotine pouch pharmacokinetics and abuse liability: Protocol for a randomized crossover study in adults who use tobacco

Brittney L Keller-Hamilton, Marielle C. Brinkman, Theodore L. Wagener, Yoo Jin Cho et al.
3 links
PLoS ONE
Smoking Behavior and Cessation
article

Impact of nicotine concentration, form, and stereoisomer ratio on oral nicotine pouch pharmacokinetics and abuse liability: Protocol for a randomized crossover study in adults who use tobacco

Brittney L Keller-Hamilton, Marielle C. Brinkman, Theodore L. Wagener, Yoo Jin Cho, Hayley Curran, Alice Hinton, Patrick M. Tomko
article en

Abstract

OBJECTIVES: Oral nicotine pouches (ONPs) are tobacco-free products placed between the lip and gum to deliver nicotine. Sales have grown rapidly in the United States (U.S.), yet independent data on how nicotine characteristics shape ONP appeal and addiction potential are lacking. Three nicotine characteristics vary across ONPs: concentration (mass of nicotine per pouch), form (the fraction of freebase, or unprotonated, nicotine), and stereoisomer (the proportion of S- to R-nicotine). This study will determine how these characteristics independently and jointly affect ONP nicotine pharmacokinetics and user experience among adults who smoke cigarettes or use moist snuff. DESIGN AND PARTICIPANTS: This randomized, double-blind, crossover trial will enroll 160 adults who smoke cigarettes or use moist snuff at a single U.S. site. INTERVENTIONS AND OUTCOMES: Participants will be randomized 1:1 to a lower (3 mg) or higher (6 mg) nicotine concentration arm. Within each arm, participants will complete five laboratory sessions in balanced, randomized order: four standardized ONP sessions (30 minutes, with the pouch placed between lip and gum) varying by nicotine form (30% vs. 70% freebase) and stereoisomer ratio (racemic [50% R- and 50% S-nicotine] vs. > 99% S-nicotine), plus one session using their usual tobacco product. Sessions will be separated by at least 48 hours. The primary outcome is maximum plasma nicotine concentration (Cmax). Secondary outcomes include time to maximum concentration (Tmax), total nicotine absorbed over 90 minutes (AUC), subjective effects, and behavioral economic demand indices. CONCLUSIONS: This will be the first study to systematically examine how nicotine concentration, form, and stereoisomer ratio interact to influence ONP abuse liability. Findings will identify which product characteristics drive ONP addiction potential and will inform FDA regulation aimed at maximizing the potential for ONPs to serve as a harm reduction alternative to cigarettes and moist snuff. TRIAL REGISTRATION: ClinicalTrials.gov NCT06315881; registered February 14, 2024.

PLoS ONEVol. 21(11)
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US), The Ohio State University Wexner Medical Center (US), The Ohio State University (US)
Ohio State University, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics, National Cancer Institute
Good health and well-being
Smoking Behavior and Cessation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon